Traykor tab. 145mg №30

Description of Tricor tabs. f/c 145mg x 30: Use Therapeutic efficacy should be assessed by lipid concentrations (total cholesterol, LDL, triglycerides) in blood serum. If there is no therapeutic effect after several months of therapy (usually after 3 months), the advisability of concomitant or alternative therapy should be considered. How to take Tricor 145 mg tablets should be swallowed whole, not chewed, with water. The drug can be taken at any time of day, regardless of meal times. - Adults: one Tricor 145 mg tablet once daily. - Patients taking one capsule of micronized fenofibrate 200 mg or one tablet of micronized fenofibrate 160 mg (Tricor at a dose of 160 mg may also be used) per day may switch to taking 1 tablet of Tricor 145 mg without additional dose adjustment. Contraindications - Patients who develop increased activity of ''hepatic'' transaminases during treatment require attention, and if ALT and AST activity increases more than 3 times compared to the upper limit of normal, the drug should be discontinued. - If symptoms of hepatitis (jaundice, skin itching) appear, laboratory tests should be performed, and if the diagnosis of hepatitis is confirmed, Tricor should be discontinued. - Cases of pancreatitis have been reported during treatment with Tricor. - Clinical data on the effect of the drug on fertility in men or women are absent. Sufficient data on the use of fenofibrate in pregnant women are not available. Embryotoxicity was noted when doses toxic to the maternal organism were administered during preclinical trials. When high doses of the drug were taken, prolongation of pregnancy and complications during childbirth were noted. The potential risk to humans is unknown.